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Effect of the Incorporation of Amaranth
(Amaranthus Mantegazzianus) into Fat- and
Cholesterol-Rich Diets for Wistar Rats
Mart´ın S. Sisti, Adriana Scilingo, and Mar´ıa Cristina An˜o´n
Abstract: The hypocholesterolemic effect of amaranth was studied in male Wistar rats fed a high-fat diet that was
supplemented with amaranth flour, AF, or isolated protein, AI. Likewise, an in vitro test was carried out, in which the
capacity of the AI, AF, the digested isolate, DAI, and the digested amaranth flour, DAF, to displace the cholesterol of the
model micelles was evaluated. The in vivo results showed an increase in the excretion of cholesterol through feces (77%
for AF7; 23% and 108% for AI30 and AF30, respect control) and a decrease in the content of hepatic cholesterol (98% for
AF7; 96% and 53% for AI30 and AF30 respect control); whereas in vitro it was shown that both AF and DAF have greater
power to displace cholesterol than the AI and DAI (IC50 0.1, 0.71, 0.2, and 2.1 for AF, DAF, AI, and DAI, respectively).
These evidences show that the proteins and fibers of amaranth have an effect on cholesterol metabolism.
Keywords: amaranth, cholesterol, hypocholesterolemia, fiber, peptides
Practical Application: Nowadays, consumers give great importance to the effect that food has on health. The results
shown in this work evidence the potential hypocholesterolemic activity presented by amaranth, this is of great importance
due to the increase in the incidence of dyslipidemia in the world population and the importance of amaranth as a
nonextensive crop of excellent agronomic, nutritional, and bioactive properties suitable for preparation of functional
foods.
Introduction
Nontransmissible diseases (NTD) are the main cause of
mortality worldwide. More than 40 million deaths due to NTD
are reported yearly, with these diseases affecting people of all ages,
regions, and countries (World Health Organization, 2018). The
main NTD are the cardiovascular and respiratory diseases, cancer,
and diabetes. NTD are all influenced by genetic, physiological,
environmental, and behavioral factors. Smoking, a sedentary
lifestyle, excessive alcohol ingestion, and unhealthy diets are
habits that increase the risk for NTD (Ministerio de Salud de
la Nacio´n, 2011). A sedentary behavior and the ingestion of
unhealthy diets can cause hypertension, overweight and obesity,
hyperglycemia, and hyperlipidemia, which are risk factors for
metabolic syndrome. It is estimated that hypercholesterolemia,
the most frequent type of hyperlipidemia, causes 2.6 million
deaths yearly, which represents 2% of the total number of deaths
globally (Ministerio de Salud, 2009; Ministerio de Salud de la
Nacio´n, 2011; World Health Organization, 2018).
Food proteins are not only an essential amino acids source, they
also give rise to peptides with biological activity, biopeptides,
encrypted in their sequences and released during gastrointestinal
digestion and/or food processing (Sa´nchez & Va´zquez, 2017).
Many studies carried out in animal models and humans have
demonstrated that proteins also have a strong impact on health
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by decreasing the lipid levels in individuals with dyslipidemia
(Boachie, Yao, & Udenigwe, 2018; Howard & Udenigwe, 2013).
In addition to proteins, other components such as phenolic com-
pounds, free or bound to carbohydrates, lipids, or proteins have
shown has hypolipidemic, antihypertensive, antiinflammatory,
and antitumor activities (Alu’datt et al., 2017).
The consumption of soy, amaranth, hemp, and lupine proteins
helps prevent hypercholesterolemia by either hampering the ab-
sorption of exogenous cholesterol (Cho) or by modulating its
biosynthesis. It has been demonstrated that the former effect is
the result of a decrease in micellar solubility of Cho and/or a
modulation of enterocyte membrane transporters (Boachie et al.,
2018).
Amaranth seeds are high in protein, near to 15% (w/w), and
their essential amino acid composition is close to the optimum
amino acid balance required in the human diet (Ogrodowska,
Zadernowski, Czaplicki, Derewiaka, & Wronowska, 2014). They
are a very good source of healthy lipids, like unsaturated fatty
acids, and bioactive compounds like tocopherols, squalene, and
biopeptides, between others (Ogrodowska et al., 2014; Tovar-
Pe´rez, Lugo-Radillo, & Aguilera-Aguirre, 2019; Velarde-Salcedo,
Bojo´rquez-Vela´zquez, & Barba de la Rosa, 2019). Different
studies show that amaranth biopeptides in addition to presenting
cho-lowering activity, present antithrombotic, antioxidant, and
antihypertensive activity, which is why they have a potential appli-
cation in foods as a functional component (Cha´vez-Ja´uregui et al.,
2010; Orsini-Delgado et al., 2016; Lado, Burini, Rinaldi, An˜o´n,
& Tironi, 2015; Plate & Areˆas, 2002; Quiroga, Aphalo, Nardo, &
An˜o´n, 2017; Sabbione, Rinaldi, An˜o´n, & Scilingo, 2016).
Although there is an extensive literature on the relationship
between diet and lipid metabolism (Escudero, Zirulnik, Gomez,
Mucciarelli, & Gime´nez, 2006; Frota, Mendonc¸a, Saldiva, Cruz,
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& Areˆas, 2008; Grajeta, 1999; Lado et al., 2015), there is still no a
clear knowledge about the action exerted by different components
present in seeds—proteins and fibers among others—nor a relation
between their possible mechanisms of action, evaluated by means
of in vitro assays, and the effect exerted in vivo. For that reason, the
aim of this work was to assess the potential Cho-lowering capacity
of amaranth in vivo in male Wistar rats fed with fat and Cho-rich
diets supplemented with an amaranth isolate (AI) or with amaranth
flour (AF), during 7 and 30 days. The capacity of AI and AF to
displace Cho from model micelles before and after subjecting the
preparations to a simulated digestion process (DAI and DAF) was
also evaluated.
Materials & Methods
Plant material, sample preparation, and chemical
characterization
Amaranthus mantegazzianus seeds, line AMAN-G1/3 2015 har-
vested in Rı´o Cuarto, Co´rdoba, Argentina, were used. The AF
was obtained with a cyclone mill (1 mm mesh). To prepare the
AI, the flour was defatted with n-hexane (10 g flour/100 mL
n-hexane) for 24 hr at room temperature, with constant stirring
during the first 5 hr and then with overnight contact. The pro-
tein isolate was prepared according to Martinez and An˜o´n (1996).
Briefly, defatted flour was suspended in water and pH was ad-
justed to 9. The suspension after 30 min stirring at 25 °C was
centrifuged (9000 × g, 20 min at 10 °C). The supernatant was
harvested and storage proteins were precipitated at the isoelectric
point (pH 5). After centrifuging (10000 × g, 20 min, 4 °C), the
sediment was separated, suspended in water, and adjusted to neu-
tral pH, freeze dried, and stored at 4 °C, until use. The procedure
was repeated several times. All the preparations were pooled to
perform the experiments. The protein content was determined
by micro-Kjeldahl method (Nkonge & Ballance, 1982) using a
conversion factor of 5.85 (Paredes Lopez, 2000). The following
methods were also applied: 2 hr hydrolysis with 1.2 M hydrochlo-
ric acid at boiling temperature followed by the anthrone method
for carbohydrates, heating in a muffle at 550 °C for the determi-
nation of total ashes, drying in a stove at 105 °C until constant
weight for water content, and sequential enzymatic digestion by
heat stable α-amylase, protease, and amyloglycosidase according
to AOAC methods 923.03, 925.09, and 991.43, for quantification
of total dietary fiber (Association of Official Analytical Chemists,
2006). Every determination was performed at least in duplicate.
In vivo experiments
Diets were prepared at the Nutricio´n y Bromatologı´a, Facul-
tad de Farmacia y Bioquı´mica, Univ. de Buenos Aires, Buenos
Aires, Argentina, and were formulated according to the Ameri-
can Institute of Nutrition, using AIN-93 as base diet (Table 1,
BD; Reeves, Nielsen, & Fahey, 1993). All diets were prepared
with casein (Dilsa, Lanu´s, Argentina), l-cystine (Anedra, San Fer-
nando, Argentina), soybean oil (Molinos Rı´o de La Plata, Victoria,
Argentina), choline chloride (Sigma), micro-crystalline cellulose
(Cofem), dextrin (Cofem), vitamins, and minerals.
A total of 36 male 11 to 12 weeks old Wistar rats (345–
377 g of body weight), provided by Instituto de Investigaciones
Bioquı´micas de La Plata bioterium, Facultad de Ciencias Me´dicas,
Univ. Nacional de La Plata, Argentina, were used in this assay.
The present protocol (T04-02:2015) was approved by the Insti-
tutional Committee for the Care and Use of Laboratory Animals
(CICUAL, Facultad de Ciencias Exactas, Univ. Nacional de La
Plata, Argentina).
Animals were divided into six groups of six animals each. After 1
adaptation week with the AIN-93 diet, five groups began to be fed
the diets under study. The control group received the control diet,
prepared by adding pork fat (10% [w/w]; Dinamarg SA, Loma del
Mirador, Buenos Aires, Argentina) and Cho (2% [w/w]; Sigma, St.
Louis, MO, USA) to base diet (Table 1 and 2). The remaining four
groups were divided into two feeding schemes. Animals subjected
to one of the schemes were fed for 30 days with a diet in which 25%
of the casein was replaced by amaranth protein as either protein
isolate (AI30) or as amaranth flour (AF30). In the other scheme,
animals were fed for 7 days with a diet in which 50% of the casein
was replaced by amaranth protein (AI7 and AF7) (Table 1 and 2).
The sixth group of animals, BD group (Table 2, BD basic diet),
was fed with the AIN-93 diet throughout the experiment.
Animals were placed in stainless steel cages, three rats per cage, in
a room with controlled lighting (12 hr of light, 12 hr of darkness)
and temperature (18 and 20 °C). Food and water were given ad
libitum. During the last week of the trial, animals were placed
individually in metabolic cages in order to collect the feces. The
fecal matter was collected, weighed, lyophilized, milled, and stored
at 20 °C until used. Before sacrifice, animals were fasted for 12 hr
and anaesthetized with pentobarbital/diazepam. The whole blood
volume was collected by cannulation of the abdominal aorta into
heparin-coated tubes. The plasma was obtained by centrifugation
of blood samples at 1500 × g for 10 min at room temperature.
The liver of each animal was resected, weighed, fractionated, and
immediately frozen in liquid nitrogen.
The content of triacylglycerides (TAG) was determined by TG
color GPO/PAP AA, Wiener Laboratorio SAIC, Rosario, Ar-
gentina. The content of total Cho, and low- and high-density
lipoproteins (LDL and HDL) were determined, by Enzymatic
Colestat, LDL precipitating reactive, and HDL precipitating reac-
tive, Wiener Laboratorio SAIC, Rosario, Argentina.
The total lipid (TL) content was determined in livers. Briefly,
1 g of liver was homogenized in 20 mL of the Folch, Lees, and
Sloane Stanley (1957) reagent (chloroform/methanol, 2/1). The
homogenate was then quantitatively transferred to a ground glass
test tube and 2 mL of water were added. The preparation was
mixed by inversion and left to settle overnight for phase separation.
The upper aqueous phase was then separated, and the extract was
filtered through filter paper containing anhydrous sodium sulfate
to retain the aqueous residues. The lipids fraction was obtained
and weighed after evaporating the chloroform phase. The lipids
extract was suspended with Triton X-100 (5 g/L) and aliquoted
to determine the content of Cho and TAG. The content of
phospholipids, PL, was determined colorimetrically by measuring
the phosphorus content in the suspension after wet digestion with
perchloric acid (Chen, Toribara, & Warner, 1956). Freeze-dried
feces (0.2 g) were mixed with 2 mL of a 10 M NaOH and
96% ethanol (1/2, v/v) mixture. Suspensions were homogenized
and incubated at 70 °C for 45 min. After cooling at room
temperature, samples were centrifuged (5 min, 1000 × g, room
temperature). The supernatant was extracted twice with 1 mL of
hexane. Hexane phases were pooled and washed with 70% (v/v)
ethanol to reach neutrality. The solvent was then evaporated. The
solid extract obtained was suspended in acetonitrile/isopropanol
(70/30 v/v), stirring for 75 min at 600 rpm and 23 °C, and
analyzed by RP-HPLC using a C18 Symmetry column (150 mm
× 4.4 mm ID, 5 µm). The flow rate was set at 1 mL/min at
35 °C. The absorbance of eluates was monitored at 210 nm. A
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Table 1–Formulation and Energy provided by diets.
Diets composition
Control AI30 AF30 AI7 AF7 AIN-93/BD
Ingredients (g/kg)
Casein 140 104 105 68 70 140
Dextrin 640.7 640.7 492.7 640.7 344.7 720.7
Soy oil − − − − − 40
Fiber 50 50 50 50 50 50
Choline 2.5 2.5 2.5 2.5 2.5 2.5
L-Cystine 1.8 1.8 1.8 1.8 1.8 1.8
Mix of vitaminsa 10 10 10 10 10 10
Mix of mineralsa 35 35 35 35 35 35
Cholesterol 20 20 20 20 20 −
Pork fat 100 100 100 100 100 −
Amaranth isolate − 36 − 72 − −
Amaranth flour − − 183 − 366 −
Energy (kcal/kg) 4202.8 4171.12 4200.97 4139.44 4199.14 3802.8
aAccording to recommendations of AIN-93 for rodents (Reeves et al., 1993).
Table 2–Design of the experiment with animals. Time of feeding and diets used.
Animals groups Feeding time (in weeks)
Names Number of rats AIN-93 Control diet Specific diet
Source of
amaranth protein
Percentage of casein
replacement (%)
BD 6 6 − − − −
Control 6 1 5 − − −
AI30 6 1 − 4 Isolate 25
AF30 6 1 − 4 Flour 25
AI7 6 1 4 1 Isolate 50
AF7 6 1 4 1 Flour 50
calibration curve with pure Cho solutions (0.1–0.5 mg/mL) was
used.
In vitro assay
Preparation of amaranth samples. The DAI and DAF were
prepared according to the protocols described by Gawlik-Dziki,
Dziki, Baraniak, and Lin (2009), Minekus et al. (2014), and Ver-
santvoort, Oomen, Van de Kamp, Rompelberg, and Sips (2005)
with some modifications. Briefly, 300 mg of AF or lyophilized
AI were suspended in 6 mL of salivary-like fluid (2.38 g/L
Na2HPO4, 0.19 g/L KH2PO4, 0.3 g/L NaCl, pH 6.8, 60 mg
of α-amylase) and shook at 37 °C for 5 min. Then 12 mL
of gastric-like fluid (2.5 g/L pepsin in 0.03 M NaCl, pH 2)
were added at 37 °C and stirred for 60 min. Later, 12 mL of
duodenal-like fluid (3 g/L pancreatin in 0.1 M NaHCO3 pH 7)
were added at 37 °C, and stirred for 60 min. Finally, all enzymes
were inactivated by heating the mixtures for 10 min at 80 °C.
The digests obtained were lyophilized and stored at 4 °C. The
degree of hydrolysis (DH%) was determined by quantifying free
amino groups by the o-phthaldialdehyde method (OPA; Sigma)
according to Nielsen, Petersen, and Dambmann (2001). The
DH% was calculated according the following expression:
GH% = [(NH2t − NH2t0) /NH2 total] × 100
where NH2t, NH2t0 are the free amino groups at time t and zero
time of hydrolysis; NH2 total is the total amino groups present in
the protein calculated as:
NH2 total = NH2∞ − NH2t0 and
NH2∞ = (1/MWaa average) ×
(
1 + fLys
) × Cprot
where NH2 corresponds to the free amino groups of a com-
pletely hydrolyzed sample; MWaa is the average of the molecular
weights of the amino acids in the sample protein. For amaranth
proteins 130 g/mol is considered; fLys is the proportion of lysine
in the samples (1/20) (Bressani & Garcia-Vela, 1990) and Cprot is
the concentration of the sample used in the test (g/L).
Displacement of cholesterol in model micelles. The ex-
clusion of Cho from model micelles was assessed as described by
Nagaoka et al. (2001) with slight modifications. Micelles were
prepared as follows: 5 mL of a solution containing sodium tau-
rocholate (6.6 mM), Cho (0.5 mM), oleic acid (1 mM), phos-
phatidylcholine (0.6 mM), NaCl (132 mM), and sodium phos-
phate (15 mM), pH 7.4 were sonicated with pulses of 10 s (with
10 s in between) for 2 min at 50% intensity in either the presence
or absence of amaranth samples (AI, DAI, AF, and DAF at 0.01–
5.00 mg protein/mL). Micelles were incubated for 2 hr at 37 °C
with shaking and then centrifuged at 70000 × g for 1 hr at 20 °C.
Free Cho in the supernatant (ChoS) and micellar Cho in the pellet
(ChoP) were quantified by HPLC. To calculate the percentage of
Cho displaced from the micelles, the following formula was used,
where the blank corresponds to the micelles formed in the absence
of amaranth:
% of displacement =(
ChoS
ChoS + ChoP −
ChoS blank
(ChoS + ChoP) blank
)
100 (1)
Measurement of model micelle size. DLS determinations
of model micelles prepared with and without amaranth were made
at a constant scattering angle in all cases using a photon correlation
spectrometer which allows size measurements of particles with
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sizes between 0.6 nm and 6 µm from INIFTA Facultad de Ciencias
Exactas, UNLP, or from Departamento de Industrias, Facultad de
Ciencias Exactas y Naturales, UBA (Zetasizer NanoZS, Malvern
Instruments Ltd., UK). The Zetasizer NanoZS uses a laser at
the light wavelength of 633 nm. All measurements were carried
out in triplicate at 37 °C after 5 min of equilibration; the values
reported are the average of at least three independent samples
(Rupp, Steckel, & Mu¨ller, 2010).
Statistical analysis
Results showed were evaluated using one-way analysis of vari-
ance (ANOVA) with the post hoc Dunnett’s test for in vivo exper-
iments or using ANOVA with the post hoc Tukey’s test for in vitro
assays. IC50 values were calculated using GraphPad Prism program.
Results and Discussion
Diets and animal weight gains
Table 1 shows the composition of the hypercholesterolemic diets
Control, AI30, AF30, AI7, and AF7, used to feed the different
groups of male Wistar rats. The diets contained the same amount
of Cho and pork fat, but they differed in the origin and amount
of added protein, as well as in the time of consumption (Table 2).
The AF contained 13.6 ± 0.4% proteins, 7.3 ± 0.2% lipids,
69 ± 3% carbohydrates, 2.4 ± 0% ashes, and 8.2 ± 0.2% water. In
addition to proteins, the AF added other components to the diet,
such as fiber, starch, triglycerides, squalene, and salts. Due to its
composition, AI mainly contributed proteins to the diets (80.7 ±
0.6%), with carbohydrates as soluble fiber, lipids, ashes, and water
being minor components (8.3 ± 0.2%, 1.2 ± 0.1%, 2.6 ± 0.1%,
and 8.55 ± 0.06%, respectively).
The lipid-rich diets employed had similar energy densities, in
the order of 4100 to 4200 kcal/kg, and equivalent contents of
carbohydrates, fibers, ashes, fat and Cho (Table 1). All diets differed
from the AIN-93 diet in the Cho and fat contents, and therefore,
in the energy value.
Table 3 shows the daily consumption of feed, the weight gains,
and the food efficiency for the different groups. All the animals
ingested similar amounts of food, except for those belonging to
group AF7, which ingested a significantly lower amount of feed
than the rest of the animals (35% lower, P < 0.05). However, this
difference in the amounts of feed ingested was reflected neither in
the weight gain, nor in the food efficiency values.
Although the animals of the BD group consumed the same
amount of food as those of the other groups, and though not sig-
nificant, they showed a difference in the weight gain and the daily
weight gain. This finding could be attributed to the consumption
of lower amounts of fat.
Lipid profiles in plasma, liver, and fecal matter
Animals fed for a long time with a diet containing low
quantities of amaranth proteins. The consumption of the
control diet increased total Cho plasma levels (12%; Figure 1A) and
decreased those of HDL (13%; Table 4), as compared to the BD
group. The liver weights of animals fed with the control diet were
markedly increased (35%). The contents of PL, TL, and Cho were
also increased (70%, 125%, and 20%, respectively), as compared
to animals of the BD group (Table 4; Figure 1B). Importantly,
animals of the BD group excreted 0.36 ± 0.07 mg of Cho/day/g
of food, whereas the excretion of Cho in feces in the Control
group was 9.5 times higher (Figure 1C).
The AI30 group, fed for a prolonged period with the diet
containing casein and AI (75/25), presented the same content of
plasma HDL, LDL, and TAG (Table 4) and a slightly higher Cho
level (7%) than animals belonging to Control group (Figure 1A).
The content of TL (Table 4) and Cho (Figure 1B) in the liver of
these animals was 36% and 96% lower, respectively, than that of
Control group, whereas the levels of TAG and PL were similar
in both groups (Table 4). The amount of Cho in the feces of the
animals of this group was 23% higher, as compared to Control
group (Figure 1C).
Animals belonging to group AF30 showed a different behavior.
The levels of plasma HDL, LDL, TAG (Table 4), and Cho
(Figure 1A) did not differ from those corresponding to Control
group. The same phenomenon was observed for liver TL, TAG,
and PL (Table 4). Furthermore, the amount of Cho in the liver
was nearly half of that detected in Control group, (53% lower,
Figure 1B), whereas the excretion of Cho in feces doubled that
obtained in Control group (108%, Figure 1C).
There was a small difference in the content of amaranth protein
between the AI30 and AF30 diets (2.9 and 2.5 g/100 g of diet, re-
spectively); however, the fiber content was roughly 1.2% and only
0.03% for AF30 and AI30, respectively. These diets also differed
in the lipidic contribution from amaranth, which was 0.035% and
0.18% for AI30 and AF30, respectively. When comparing the re-
sults obtained in the animals fed AI30 and AF30, we observed
differences in the quantities of plasma and liver Cho, as well as in
the amount of Cho in feces. The data obtained clearly indicate
that the presence of fiber promotes the excretion of Cho in feces,
because the animals belonging to group AF30 excreted 68% more
Cho than those belonging to AI30. The products resulting from
the gastrointestinal digestion of amaranth proteins, that is, pep-
tides of different size and composition, were capable of altering
the lipid metabolism and slightly affecting the excretion of Cho,
as observed in the AI30 group. It can be speculated that peptides
resulting from the digestion process enhance the effect exerted by
fiber in animals fed AF. Although an effect of the components
of the amaranth lipid fraction cannot be ruled out, it should be
minimal if we consider that the animals ingested 16 to 18 g of food
per day, contributing less than 0.001 g of amaranth lipids/day.
Although the Cho-lowering capacity of cereal and pseudocereal
proteins added to Cho-rich diets has been extensively studied, the
results are difficult to compare, because different protein sources,
animal models, and different diets were used.
The studies carried out by Lado et al. (2015) and Escudero
et al. (2006) with Wistar rats with diets containing isolated or
amaranth protein concentrates have been shown a modification of
the lipid profile in animals, particularly in liver, and increases in the
excretion of Cho in feces. Grajeta (1999) has shown that Buffalo
rats fed for 28 days on a diet containing 4% amaranth fiber from
whole seed, 15% fat, 20% protein provided by casein and amaranth
seed, and 0.5% Cho reduced the content of plasma and hepatic
Cho whereas decrease TAG in the liver. This author attributed the
lipid-lowering effect to the fiber present in the amaranth seed and
considered that proteins, tocotrienols, unsaturated fatty acids, and
vitamin E could play a role in the Cho-lowering effect.
Although the results obtained by these authors show the same
tendency as those of the present work, it should be noted that
we have obtained these results feeding the animals with a much
smaller amount of proteins from amaranth, AI replaced only 25%
of the casein present in AIN-93. Besides, under our experimen-
tal conditions, the hypercholesterolemic effect of casein was not
counteracted by the addition of AI.
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Table 3–Amount of food, weight of animals, and food efficiency in the groups of rats studied.
Animals groups
Control
(mean ± SEM)
AI30
(mean ± SEM)
AF30
(mean ± SEM)
AI7
(mean ± SEM)
AF7
(mean ± SEM)
BD
(mean ± SEM)
Daily intake (g/day) 17.4 ± 0.5 16ns ± 0.8 18.2ns ± 0.8 15.2ns ± 0.9 11.7∗ ± 0.6 19ns ± 1
Total diet intake (g) 3136 2883 3276 638 492 3504
Body weight (g)
Initial 377 ± 18 345 ± 9 328 ± 16 346 ± 11 322 ± 5 369 ± 17
Final 432 ± 16 395 ± 9 373 ± 9 374 ± 8 368 ± 7 399 ± 22
Weight variation (g) 55 ± 28 50ns ± 13 45ns ± 26 28ns ± 16 46ns ± 12 29ns ± 13
Weight gain per day
(g/day)
1.8 ± 0.8 1.6ns ± 0.4 1.5ns ± 0.8 0.9ns ± 0.5 1.5ns ± 0.4 0.6ns ± 0.3
Food efficiency (%)a 11 ± 5 10ns ± 3 8ns ± 4 6ns ± 3 13ns ± 3 5ns ± 2
ns, nonsignificative differences compared with Control.
∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005, ∗∗∗∗P < 0.0001 significant differences compared with Control (one-way analysis of variance [ANOVA], with the post hoc Dunnett’s test).
aFood efficiency % = (weight gain/food intake) × 100.
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Figure 1–Cholesterol quantification in animals fed during 30 days with diets containing amaranth flour (AF30) or amaranth protein isolate (AI30),
replacement 25% of casein of the base diet. Cho in feces (A), in liver (B), and in plasma (C). ∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005), ∗∗∗∗P < 0.0001
significant differences compared with Control (analysis of variance [ANOVA] with the post hoc Dunnett’s test).
Table 4–Lipids in liver and in blood of rats. Liver weight and total blood volume.
Animals groups
Control
(mean ± SEM)
AI30
(mean ± SEM)
AF30
(mean ± SEM)
AI7
(mean ± SEM)
AF7
(mean ± SEM)
BD
(mean ± SEM)
Liver
Liver weight (g) 12.4 ± 0.8 11.2ns ± 0.3 11.8ns ± 0.8 11.3ns ± 0.5 11.1ns ± 0.9 8.9∗∗ ± 0.6
Phospholipids - PL
(mg/100 mg of liver)
1.93 ± 0.09 1.7ns ± 0.06 1.86ns ± 0.07 1.42∗∗∗ ± 0.02 1.73ns ± 0.12 1.13∗∗∗∗ ± 0.07
Triacylglycerides (TAG)
(mg/100 mg of liver) 1.1 ± 0.1 1.02 ns ± 0.07 0.95 ns ± 0.05 1.05 ns ± 0.06 0.80 ns ± 0.05 1.08 ns ± 0.07
Total lipids (TL)
(mg/100 mg of liver) 14 ± 1 9∗∗ ± 1 13ns ± 0.8 15.4ns ± 0.9 12.2ns ± 0.9 6.2∗∗∗∗ ± 0.5
Blood
Volume (mL) 9.4 ± 0.3 8.7ns ± 0.4 9.1ns ± 0.7 9.9ns ± 0.2 6.7∗∗∗ ± 0.3 7.7ns ± 0.8
HDL (g/L)a 0.34 ± 0.01 0.37ns ± 0.01 0.37ns ± 0.01 0.33ns ± 0.01 0.34ns ± 0.00 0.39∗∗ ± 0.01
LDL (g/L)b 0.33 ± 0.01 0.35ns ± 0.01 0.33ns ± 0.00 0.37ns ± 0.01 0.3∗∗ ± 0.01 0.33ns ± 0.01
TAG (g/L)c 1.38 ± 0.03 1.41ns ± 0.03 1.29ns ± 0.02 1.31ns ± 0.03 1.2∗∗∗ ± 0.03 1.4ns ± 0.1
ns, nonsignificative differences compared with Control.
∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005, ∗∗∗∗P < 0.0001 significant differences compared with Control (one-way analysis of variance [ANOVA], with the post hoc Dunnett’s test).
aHDL, high-density lipoproteins.
bLDL, low-density lipoproteins.
cTAG. triacylglycerides.
Studies carried out with other animal models and proteins have
shown similar results to those obtained in this work as concerns
the modification of the lipid profile in the liver and the excretion
of Cho in feces, whereas the modifications detected in the lipid
profile of the plasma were variable (Frota et al., 2008; Mendonc¸a,
Saldiva, Cruz, & Areˆas, 2009; Takao et al., 2005; Villanueva,
Yokoyama, Hong, Barttley, & Rupe´rez, 2011).
Animals fed for a short period with diets containing
high amounts of amaranth protein. The AI7 group, fed with
a high proportion of AI (casein/AI, 50/50), presented increased
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Figure 2–Cholesterol quantification in animals fed during 7 days with diets containing amaranth flour (AF7) or amaranth protein isolate (AI7),
replacement 50% of casein of the base diet. Cho in feces (A), in liver (B), and in plasma (C). ∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.0005), ∗∗∗∗P < 0.0001
significant differences compared with Control (analysis of variance [ANOVA] with the post hoc Dunnett’s test).
plasma Cho levels, as compared to Control group (18%, Figure 2A)
and a minor content (27%) of PL in the liver (Table 4). The
levels of LDL, HDL, and TAG in plasma (Table 4) and of Cho
in liver (Figure 2B) were equivalent to those of Control group.
No differences were detected in the excretion of Cho in feces
(Figure 2).
The inclusion of AF caused different effects in the animals. The
levels of plasma LDL, TAG, and Cho were lower (reductions of
12%, 14%, and 38%, respectively; Table 4; Figure 2A), whereas
the content of Cho in the liver decreased dramatically (reduction
of 98%) with respect to Control group (Figure 2B). These animals
also excreted higher amounts of Cho than animals of Control
group (approximately 77%, Figure 2C). The animals that were fed
with the AF7 diet received a greater amount of fiber and a smaller
quantity of amaranth protein than those fed with the AI7 diet
(approximately 2% and 0.06% of fiber; 5% and 5.8% of protein
from amaranth, respectively). Animals from groups AF7 and AI7
also received 2.7 and 0.08 g/100 g of amaranth lipids. In agreement
with previous works, the results obtained herein suggest that the
amaranth fiber has a high capacity to interfere with the absorption
of dietary Cho and that after digestion, the amaranth proteins
lose part of the Cho absorption-blocking capacity; however, their
effect on lipid metabolism is more specific. Although an effect
exerted by components of the amaranth lipid fraction cannot be
ruled out, their contribution is negligible considering the amounts
of feed ingested by the animals daily (12–15 g of food/day).
Recent studies carried out by Wang, Nagaoka, Kusada,
Shimada, and Kato (2014) in Wistar rats fed for a short period
with a Cho-rich diet containing casein and rice bran protein as a
protein source, and fiber, have shown a reduction of plasma Cho,
as compared to animals fed only with casein, and an increase in the
level of neutral and acid steroids in feces, respectively. The results
obtained in the AF7 group showed the same trend described by
Wang et al. (2014), though in our study, animals received lower
protein and higher fiber amounts than the ones used byWang et al.
(2014). Furthermore, our results are supported by a level decrease
of LDL and TAG in plasma (Table 4).
In vivo experiments demonstrated that the amaranth fiber would
interfere with the absorption of dietary Cho and might also affect
the enterohepatic circulation of bile salts. This effect is currently
being analyzed in our laboratory. A complete characterization of
the fiber present in the amaranth seed has not been performed.
However, recent work has shown that amaranth fiber is constituted
by 78% of insoluble fiber rich in pectin, and 22% of soluble fiber
consisting mainly of arabans and xylans (Lamothe, Srichuwong,
Reuhs, & Hamaker, 2015).
To date, no studies have been performed to assess the hypoc-
holesterolemic properties of pseudocereal proteins added to Cho-
rich diets for short periods.
The studies carried out herein also suggest that the hydrolysis
products of the amaranth proteins generated during the digestion
process in animals have a much lower capacity to increase the
excretion of Cho. Furthermore, some aspects cannot be ruled
out, such as an interaction between these peptides and bile salts,
their capacity to modify the activity of some key enzymes of Cho
metabolism for example, HMGR, and/or the capacity tomodulate
Niemann-Pick C1-like transporter, as demonstrated for amaranth
and other peptides of food origin (Matsuoka et al., 2014; Nardo,
2017; Soares et al., 2015).
Micellar solubility. The incorporation of dietary Cho into
micelles is a critical step in the absorption of Cho by enterocytes.
Given the greater excretion of Cho found in the feces of the
animals that consumed amaranth, particularly during a relatively
long period, we carried out in vitro tests to estimate the potential
effect of amaranth on the incorporation or exclusion of Cho from
micelles. Initially, the formation of the micelles was monitored by
measuring the average size of the particles obtained by sonication
of the mixtures of Cho, PL, sodium taurocholate, oleic acid, and
amaranth samples (AI, AF, and DAI and DAF). Figure 3 shows
the micelle size (mean ± standard error) obtained in the absence
of amaranth proteins. A nonnormal distribution of particles with
an important degree of polydispersity (10–200 nm) was observed,
with a maximum frequency of 53 ± 0.01 nm. It is noteworthy
that the micellar size remained stable for at least 3 hr (data not
shown).
When the micelles were formed in the presence of AI, a dis-
placement of the particle size distribution was detected towards
larger diameter values, with a maximum size of 71 ± 0.03 nm.
In the presence of AF, a polymodal distribution was detected with
a first smaller peak of 46 ± 0.02 nm and more abundant micelle
population with sizes greater than 150 ± 0.01 nm, which could
correspond to micelle aggregates and/or aggregates of some of the
components present in the mixture (Figure 3 and insert). These
results suggest that amaranth proteins can interact with some of
the components that participate in the formation of the micelle,
that is, Cho, bile acids, and/or PL, thus modifying its size. This
effect was enhanced when, in addition to proteins, fibers from
amaranth were present in the mixture, suggesting an additional
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Figure 3–Micelles size (in nm) prepared without amaranth (empty cir-
cles), with amaranth protein isolate (full circles), with amaranth flour (full
triangles), with amaranth protein isolate or amaranth flour submitted to
simulated gastrointestinal digestion (full squares and full rhombus, respec-
tively). All the maximum frequencies were significantly different respect
to the micelle without amaranth protein (P < 0.05, analysis of variance
[ANOVA] with the post hoc Tukey’s test), every determination was per-
formed at least in triplicate.
interaction of these components with the rest of the components
of the micelle.
AI and AF were subjected to a simulated gastrointestinal diges-
tion process, and the products obtained, DAI (44% DH) and DAF
(48.4% DH) were evaluated for their capacity to influence the
formation of micelles. The results obtained show, in both cases,
a larger micellar size with respect to the respective undigested
samples, with the maximum particle size of 82 ± 0.01 and 71 ±
0.02 nm for each distribution, respectively. The presence of fiber
in the DAF sample induced the formation of more than one
population of particles larger than 100 nm, as observed for AF.
During the simulated gastrointestinal digestion, proteins
decrease their molecular size while leaving the fibers present in
the AF intact. It is therefore evident that the modification of
the size of the proteins/peptides affects their ability to interact
with the other components of the micelle and that the fibers also
have the ability to bind to micelles and are responsible for the
formation of aggregates of different molecular sizes.
As far as we know, no studies have been conducted on the effect
of simulated gastrointestinal digestion products of seed flours and
protein isolates in the solubility tests.
Figure 4 shows that the interaction of the proteins and the
amaranth fibers with micelles is dose-dependent, that both com-
ponents have the capacity to interfere in the formation of micelles,
and that the size of the proteins is crucial in such interaction. The
IC50 values calculated were 0.2, 0.1, 2.1, and 0.71 mg/mL for AI,
AF, DAI ,and DAF, respectively. On the other hand, the amounts
of Cho displaced during the formation of the micelle in the pres-
ence of 1 mg/mL of proteins were 50.7 ± 0.5%, 73.4 ± 1%, 6.6 ±
1%, and 60 ± 6% (mean ± standard error all the values are signif-
icantly different P < 0.05) for AI, AF, DAI, and DAF, respectively.
This finding would indicate that the proteolysis that occurs during
the artificial gastrointestinal digestion has a negative effect on the
ability of proteins to hamper the incorporation of Cho into the
micelle. However, a concentration 3 mg/mL DAI protein induced
a displacement of 80% of the initial Cho present in the mixture,
a value that was significantly higher than the one displaced by the
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Figure 4–Displacement of cholesterol (%) from the micelles prepared with
amaranth flour (full triangles), with amaranth flour submitted to simulated
gastrointestinal digestion (full rhombus), with amaranth protein isolate
(full circles), and with digested amaranth protein isolate (full squares) in
function of protein concentration. Protein concentrations (mg/mL) that
promote 50% displacement (IC50, mean ± standard error) were 0.1 ±
0.3, 0.71 ± 0.07, 0.2 ± 0.1, and 2.1 ± 0.03 all the values are significantly
different except the amaranth protein isolatewith respect to the amaranth
flour (P < 0.05, analysis of variance [ANOVA] with the post hoc Tukey’s
test), every determination was performed at least in triplicate.
same amount of AI, which shows a maximum competitive power
of 50%. For all micellar solubility tests, we obtained a cholesterol
recovery of around 80% to 90%.
Many studies (Howard & Udenigwe, 2013; Ruiz, Ancona, &
Campos, 2014; Yust, Milla´n-Linares, Alcaide-Hidalgo, Milla´n, &
Pedroche, 2012; Zhang, Yokoyama, & Zhang, 2012) have shown
that hydrophobic peptides have greater Cho-lowering capacity
because they are stronger competitors and displace Cho from the
micelle more efficiently. Zhang et al. (2013) have also shown that
the presences of cationic amino acids in the peptide composition,
which can interact with the carboxylic groups of bile acids, are
important to accomplish the lipid-lowering effect. Interestingly,
some peptides can interact with both Cho and bile acids being its
hypocholesterolemic activity equivalent to that of the cholestyra-
mine compound that limits the absorption of cholesterol, reduces
its concentration in plasma and possesses a high affinity for bile
acids (Nagaoka, Nakamura, Shibata, & Kanamaru, 2010).
Our results are in agreement with those obtained with egg al-
bumin and cowpea protein hydrolysates (Marques et al., 2015;
Matsuoka et al., 2014; Nagaoka, Masaoka, Zhang, Hasegawa, &
Watanabe, 2002), in terms of the ability of dietary proteins to
reduce the incorporation, and possibly, the displacement, of Cho
into/out of micelles, as well as with authors showing the impor-
tance of size and composition of bioactive peptides.
To our knowledge, no studies have been reported on the effect
of fibers in micellar solubility tests.
Conclusions
In in vivo tests, we have demonstrated that both fibers and hy-
drolysis products of the amaranth proteins interfere with Cho
absorption at the intestinal level. Amaranth fiber, proteins, and the
peptides released in the digestion process are also capable of inter-
fering with the formation of micelles and of reducing the amount
of Cho that is incorporated. In a case of peptides, a greater amount
of them is required to initiate the displacement of Cho. This mech-
anism would account for the greater excretion of dietary Cho in
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feces. Fiber components and digested products, in turn, modify
the lipid profile, particularly when half of the casein present in the
diet is replaced by AF during a short period of time. The ingestion
of AI during short periods after a longer intake of the Cho-rich
diet yielded negative results, because not only was it unable to
increase the excretion of Cho, but it elevated its plasma levels.
According to these results, the consumption of foods prepared
with flour and/or amaranth protein isolates would contribute to
the reduction of cholesterol in consumers.
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